1. Home
  2. ACAD vs ALH Comparison

ACAD vs ALH Comparison

Compare ACAD & ALH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$20.83

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

ALH

Alliance Laundry Holdings Inc.

N/A

Current Price

$23.89

Market Cap

3.9B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACAD
ALH
Founded
1993
1908
Country
United States
United States
Employees
N/A
3973
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
ACAD
ALH
Price
$20.83
$23.89
Analyst Decision
Buy
Strong Buy
Analyst Count
22
8
Target Price
$30.55
$30.88
AVG Volume (30 Days)
1.5M
589.9K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
69.12
N/A
EPS
0.02
N/A
Revenue
$726,437,000.00
N/A
Revenue This Year
$18.80
$7.42
Revenue Next Year
$11.70
$5.88
P/E Ratio
$1,029.50
$35.43
Revenue Growth
40.45
N/A
52 Week Low
$19.69
$18.64
52 Week High
$28.35
$27.48

Technical Indicators

Market Signals
Indicator
ACAD
ALH
Relative Strength Index (RSI) 41.42 44.63
Support Level $20.06 $23.75
Resistance Level $22.64 $25.11
Average True Range (ATR) 0.79 0.87
MACD -0.17 -0.33
Stochastic Oscillator 18.95 23.39

Price Performance

Historical Comparison
ACAD
ALH

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

About ALH Alliance Laundry Holdings Inc.

Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.

Share on Social Networks: